Date of preparation: September 2014 L.GB d

Size: px
Start display at page:

Download "Date of preparation: September 2014 L.GB d"

Transcription

1 Date of preparation: September 2014 L.GB d This medicine is subject to additional monitoring. This will allow quick identification of new safety information. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at By reporting side effects you can help provide more information on the safety of this medicine.

2 FOREWORD It is human nature to have questions when we come across or try something new. When something new is related to our health, it s even more important that we have access to the information we need to enable us to feel comfortable. If you are preparing for treatment with Xarelto (rivaroxaban) for the prevention of venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement surgery Working in collaboration with a key patient organisation, Bayer HealthCare have developed Xarelto Xpert, to help you understand and better manage your condition. By following our five step plan this leaflet will help you become an expert by: ploring your condition roviding you with information on Xarelto and how it works xplaining how to take Xarelto evealing answers to frequently asked questions aking you to other useful sources of information We hope this leaflet helps you to feel confident about taking the next step in your treatment journey with Xarelto. Please read the Patient Information Leaflet that is in your pack of Xarelto tablets. 1

3 WHAT IS VENOUS THROMBOEMBOLISM? VTE is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE) A DVT is a blood clot that forms in the veins deep in your leg, usually in the calf or thigh, but can sometimes occur in other veins in your body. The blood clot blocks the flow of blood in the affected vein either partially or completely. A PE is usually the result of an underlying blood clot in the leg known as a DVT. The clot breaks away and travels through the body, via the heart to reach the lungs. When the clot reaches the lungs, it travels through the vessels of the lung until it reaches smaller vessels where it becomes wedged. The clot may then prevent any further blood from travelling to that section of the lung. A PE is a serious, potentially life-threatening condition which requires immediate treatment. Hospital acquired VTE is a major health risk. It has been estimated that more than 25,000 preventable deaths are associated with hospital acquired VTE each year in the UK. 1 The diagram on page 4 helps illustrate a PE. 2

4 More than 25,000 preventable deaths are associated with hospital acquired VTE each year in the UK. 1 3

5 A DVT is a blood clot that forms in the veins deep in your leg, usually in the calf or thigh The diagram above explains how a DVT and PE can occur. 4 Why does blood clot? Blood clots occur as a vital protection system in our body. When we injure or cut ourselves, a clot is formed outside of our veins to protect us from the loss of blood. This is a natural process known as the clotting cascade. However, there are times when the clotting cascade goes wrong and blood clots form inside our veins, causing a DVT. What are the causes and symptoms of a DVT? Certain people are more likely to develop a DVT than others. Risk factors include: age older people are more likely to have a DVT than younger people immobility caused by long travel journeys, illnesses or injuries having a recent operation pregnancy having severe pre-existing medical illnesses such as cancer, heart problems or respiratory disease previous experience of a DVT taking hormone-based treatment, such as the contraceptive pill and hormone replacement therapy obesity smoking.

6 A clot which has travelled up from the leg to lodge within the lung is known as a PE Some people with a DVT may have no symptoms, but common symptoms of a DVT are: tenderness in the leg redness swelling and a feeling of tightness, the skin may feel stretched pain. Some people may only realise they have a DVT when a PE develops as a result of the clot travelling to the lungs. Symptoms of a PE include: chest pain that is sharp and is worse when taking a deep breath shortness of breath sweating. What can I do to reduce the chance of having a DVT? It is important to listen to the medical team looking after you once you ve had an operation and move around when you are asked to. If you can t move easily after the operation you may be asked to do leg exercises. You may also be offered elastic compression stockings or a mechanical foot pump in order to help blood flow in your leg. Drink plenty of fluids if you are able to and if you experience any leg or chest symptoms, tell your doctor or a nurse immediately. 5

7 A STEP- BY- STEP GUIDE TO XARELTO What is Xarelto? Xarelto is an anticoagulant, which is a type of medication that slows down your body s ability to clot, therefore reducing the likelihood of dangerous blood clots forming. How does Xarelto work? The formation of a blood clot is a natural process (called the clotting cascade) within your body. For example, when you cut yourself, you will see a clot form to stop the bleeding. Xarelto belongs to a group of medicines called antithrombotic agents. It works by blocking a specific protein in the blood Factor Xa ( ten A ) which is known to play a key role in starting the blood clotting cascade process. Blocking Factor Xa prevents the formation of subsequent proteins that are also involved in the clotting cascade, so reducing the tendency for blood clots to form. How is Xarelto taken? Xarelto is taken by mouth (orally) and the usual dose for the prevention of venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement surgery is one 10mg table once a day. If you have had a hip operation you will usually take Xarelto for 5 weeks. If you have had a knee operation you will usually take Xarelto for 2 weeks. 6 The tablet should be swallowed whole, preferably with water, and can be taken with or without food. Try to take it at the same time each day to help you remember it.

8 When the lining of the blood vessel becomes damaged, platelets are activated at the site to help prevent further injury The clotting cascade is activated to form a blood clot Activates Activates Becomes Activates Activates Pt Pt Pt Pt Pt Pt Pt Proteins Xarelto works by blocking Factor Xa Prothrombin Thrombin Fibrinogen Fibrin - glue that binds platelets together to form a Factor Xa, blood clot so reducing Xarelto the ability for blood clots to form The illustration above will help you better understand how Xarelto works. Why have I been prescribed Xarelto? You have been prescribed Xarelto because you have recently undergone hip or knee replacement surgery. After surgery, you are at an increased risk of developing blood clots in your veins. Xarelto can help reduce the chances of these blood clots forming. Xarelto has been prescribed for you personally and should not be passed on to others. It is also important that you read the patient information leaflet that comes in your Xarelto pack. Xarelto is used to treat different patients for different reasons. Another person prescribed Xarelto may take a different dose from you. Always take Xarelto exactly as your doctor has told you and check with your doctor or pharmacist if you are unsure of your correct dose. 7

9

10

11 YOUR XARELTO QUESTIONS ANSWERED How do I take Xarelto? Always take Xarelto exactly as your doctor or nurse has told you to. If you are not certain, make sure you check with your medical team or pharmacist. The usual dose is one 10 mg tablet once a day. Swallow the tablet, preferably with water. Xarelto can be taken with or without food. Take the first tablet 6 to 10 hours after your operation. Then take a tablet every day until your doctor or nurse tells you to stop. Try to take the tablet at the same time every day to help you to remember it. If you have had a hip operation you will usually take Xarelto for 5 weeks. If you have had a knee operation you will usually take Xarelto for 2 weeks. It is important to take Xarelto for the recommended length of time because you may still be at risk of developing a blood clot even after you leave hospital. How should I store Xarelto? This medicine does not require any special storage conditions and can be stored in a dosing box. Keep it out of the reach and sight of children. Do not use Xarelto after the expiry date (this is stated on the pack). What if I take more Xarelto than I should have? Contact your doctor immediately if you have taken too many Xarelto tablets. Taking too much Xarelto increases the risk of bleeding. What should I know before taking Xarelto? Tell your doctor, nurse or pharmacist if you are taking, or have recently taken any other medicines, including St John s Wort and any other medicines obtained without a prescription. Xarelto contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking Xarelto. 10

12 What are the most common side effects of Xarelto? Like all medicines, Xarelto can cause side effects. As we are all different these will vary from one person to another. As Xarelto is an anticoagulant medicine that slows down your body s ability to clot, a common side effect is an increased risk of bleeding either external, visible blood loss or internal bleeding inside the body. Symptoms of bleeding include: unexplained dizziness or weakness swelling and discomfort sudden, severe headache unusual bruising, nosebleeds, bleeding of gums, cuts that take a long time to stop bleeding menstrual flow or vaginal bleeding that is heavier than normal pink or brown urine, red or black stools coughing up blood, or vomiting blood or material that looks like coffee grounds. If you have any symptoms of bleeding, tell your doctor or visit your nearest A&E department immediately so that you can be monitored and have your treatment assessed. For a full list of possible side effects, please refer to the Patient Information Leaflet provided with your Xarelto tablets. If you think you are experiencing side effects from Xarelto at any time, contact your doctor or pharmacist immediately for advice. Please remember to take Xarelto every day missing a dose will increase your risk of having a DVT. 11

13 YOUR XARELTO QUESTIONS ANSWERED Can I take Xarelto if I am intolerant to some sugars? Xarelto contains lactose and you should speak to your doctor if you have a known intolerance to some sugars before taking it. Can I drive or operate machinery whilst taking Xarelto? Xarelto may cause fainting or dizziness. If you experience these symptoms you should not drive or use machinery. Can I take Xarelto if I am pregnant or breastfeeding? It is important that you discuss this with your doctor as you must not take Xarelto if you are pregnant or breastfeeding. If there is a chance that you could become pregnant, it is essential that you use a reliable contraceptive while you are taking Xarelto. If you become pregnant while you are using Xarelto, inform your doctor immediately, who will discuss your treatment options moving forwards. When should I not take Xarelto? You must not take Xarelto: if you are allergic (hypersensitive) to Xarelto or any of the other ingredients of Xarelto if you are bleeding excessively if you have a liver disease which leads to an increased risk of bleeding if you are pregnant or breastfeeding. Speak to your doctor if any of these apply to you. If you still have questions about the use of Xarelto please ask your doctor who will be able to answer these and provide you with more information as appropriate. Date of preparation: February 201 L.GB

14 HOW TO USE YOUR XARELTO PATIENT ALERT CARD Patient Alert Card Xarelto 10 mg s Keep this card with you at all times s Present this card to every physician or dentist prior to treatment This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the patient information leaflet for how to report side effects. In the unlikely event of an emergency, a doctor treating you will need to be made aware of the existing medications you are on so that you can be cared for appropriately. The attached alert card has been designed to make the doctor aware that you are receiving treatment with Xarelto. Please carry this with you at all times. In addition, please show your card in advance of any dental treatment/operations to ensure you are treated appropriately. 13

15 USEFUL SOURCES OF INFORMATION To find out more about managing your DVT please visit the following independent websites and organisations: AntiCoagulation Europe (ACE) Tel Website Circulation Foundation Tel Website Lifeblood: The Thrombosis Charity Tel Website 14

16 MY NOTES

17 REFERENCES 1. House of Commons Health Committee. The Prevention of Venous Thromboembolism in Hospitalised Patients, Second Report of Session Available at Last Accessed February 2013.

18

Reducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge

Reducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge Reducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge What is a venous thromboembolism (VTE)? This is a medical term that describes a blood clot that develops in a deep vein

More information

Understanding your risk of blood clots from hospital to home and how Bevyxxa may help

Understanding your risk of blood clots from hospital to home and how Bevyxxa may help Understanding your risk of blood clots from hospital to home and how Bevyxxa may help People who take Bevyxxa and have medicine injected into their spinal and epidural area, or have a spinal puncture,

More information

Venous Thrombo-Embolism (VTE)

Venous Thrombo-Embolism (VTE) Venous Thrombo-Embolism (VTE) Information for service users and carers RDaSH leading the way with care Older People s Mental Health Services Reducing risk of unwanted blood clots whilst in hospital About

More information

Preventing Blood Clots in Adult Patients

Preventing Blood Clots in Adult Patients Manchester Royal Eye Hospital Surgical Services Information for Patients Preventing Blood Clots in Adult Patients This leaflet will give you information on how to reduce the risk of developing blood clots

More information

To prevent blood clots after hip or knee replacement surgery This booklet contains information for those who have been prescribed ELIQUIS (apixaban)

To prevent blood clots after hip or knee replacement surgery This booklet contains information for those who have been prescribed ELIQUIS (apixaban) To prevent blood clots after hip or knee replacement surgery This booklet contains information for those who have been prescribed ELIQUIS (apixaban) after hip or knee replacement surgery Always read the

More information

MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets

MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets What is the most important information I should know about ELIQUIS? For people taking ELIQUIS for atrial fibrillation: People with atrial fibrillation

More information

Rivaroxaban to prevent blood clots for patients who have a lower limb plaster cast. Information for patients Pharmacy

Rivaroxaban to prevent blood clots for patients who have a lower limb plaster cast. Information for patients Pharmacy Rivaroxaban to prevent blood clots for patients who have a lower limb plaster cast Information for patients Pharmacy Your doctor has prescribed a tablet called rivaroxaban. This leaflet tells you about

More information

UW MEDICINE PATIENT EDUCATION. Treating Blood Clots. What is a blood clot? DRAFT

UW MEDICINE PATIENT EDUCATION. Treating Blood Clots. What is a blood clot? DRAFT UW MEDICINE PATIENT EDUCATION Treating Blood Clots About deep vein thrombosis (DVT) and pulmonary embolism (PE) and how they are treated This handout explains blood clots, their symptoms, and how they

More information

Confirmed blood clot

Confirmed blood clot n The Leeds Teaching Hospitals NHS Trust Confirmed blood clot (Deep vein thrombosis and pulmonary embolism) Information for patients Please read this leaflet carefully. It will give you information about

More information

Treatment with Rivaroxaban Xarelto

Treatment with Rivaroxaban Xarelto Treatment with Rivaroxaban Xarelto Anticoagulation Clinic This handout explains the medicine rivaroxaban, a drug that helps prevent blood clots. What is rivaroxaban? Rivaroxaban (brand name Xarelto) is

More information

Diagnosed with DVT/PE blood clots? Your journey with XARELTO starts here.

Diagnosed with DVT/PE blood clots? Your journey with XARELTO starts here. THERE S MORE TO KNOW Diagnosed with DVT/PE blood clots? Your journey with XARELTO starts here. Do not stop taking XARELTO without talking to your doctor. Stopping XARELTO increases your risk of having

More information

HELPING TO TREAT DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM

HELPING TO TREAT DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM HELPING TO TREAT DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM AND PREVENT THEIR RECURRENCE PATIENT INFORMATION BOOKLET IF FOUND, PLEASE RETURN TO: If found, please return to: Name Address Phone number It

More information

Preventing blood clots while you are in hospital and after you leave. Information for patients Pharmacy

Preventing blood clots while you are in hospital and after you leave. Information for patients Pharmacy Preventing blood clots while you are in hospital and after you leave Information for patients Pharmacy Why does blood clot? When we cut ourselves, we bleed. To stop us from bleeding too much, chemicals

More information

Cancer and blood clots

Cancer and blood clots n The Leeds Teaching Hospitals NHS Trust Cancer and blood clots What you should know whilst you are in source isolation Information for thyroid patients Please read this leaflet carefully. It will give

More information

Reducing the Risk of Deep Vein Thrombosis (DVT) whilst in hospital and following your discharge home

Reducing the Risk of Deep Vein Thrombosis (DVT) whilst in hospital and following your discharge home Reducing the Risk of Deep Vein Thrombosis (DVT) whilst in hospital and following your discharge home 1 Part of: South Tyneside and Sunderland Healthcare Group Introduction This leaflet explains what Deep

More information

Rivaroxaban. medication do? Xarelto. is a blood. Medication. Emboli (PE).

Rivaroxaban. medication do? Xarelto. is a blood. Medication. Emboli (PE). Medication Information (Ri va rox xa - ban) Other names for this medication: Xarelto What does this medication do? This medication is a blood thinner, also called an anticoagulant. It prevents a blood

More information

Diagnosed with AFib? Your journey with XARELTO starts here.

Diagnosed with AFib? Your journey with XARELTO starts here. THERE S MORE TO KNOW Diagnosed with AFib? Your journey with XARELTO starts here. Do not stop taking XARELTO without talking to your doctor. Stopping XARELTO increases your risk of having a stroke. 2 Welcome

More information

Deep Vein Thrombosis and Pulmonary Embolism: Risks, Prevention & Treatment

Deep Vein Thrombosis and Pulmonary Embolism: Risks, Prevention & Treatment Deep Vein Thrombosis and Pulmonary Embolism: Risks, Prevention & Treatment Other formats If you need this information in another format such as audio tape or computer disk, Braille, large print, high contrast,

More information

Treatment with Apixaban Eliquis

Treatment with Apixaban Eliquis Treatment with Apixaban Eliquis Anticoagulation Clinic 416-530-6000 ext 3477 This handout explains the medicine rivaroxaban, a drug that helps prevent blood clots. What is apixaban? Apixaban (brand name

More information

Pradaxa. [dabigatran etexilate] patient support booklet

Pradaxa. [dabigatran etexilate] patient support booklet Pradaxa [dabigatran etexilate] patient support booklet Important information about your medication and how to take it to help you reduce your risk of stroke associated with atrial fibrillation You have

More information

Venous Thromboembolic Events (VTEs)

Venous Thromboembolic Events (VTEs) Venous Thromboembolic Events (VTEs) This Infosheet explains what a VTE is, what the causes and risk factors for VTEs are, the symptoms of a VTE, how they can be treated and some tips for self-management.

More information

DO YOU HAVE AFIB OR DVT/PE BLOOD CLOTS?

DO YOU HAVE AFIB OR DVT/PE BLOOD CLOTS? To significantly reduce stroke risk from AFib and to treat and help prevent DVT and PE blood clots DO YOU HAVE AFIB OR DVT/PE BLOOD CLOTS? GET TO KNOW HOW THIS LATEST-GENERATION BLOOD THINNER HELPS PROTECT

More information

Deep Vein Thrombosis

Deep Vein Thrombosis Deep Vein Thrombosis from NHS (UK) guidelines Introduction Deep vein thrombosis (DVT) is a blood clot in one of the deep veins in the body. Blood clots that develop in a vein are also known as venous thrombosis.

More information

About Blood Clots and How to Treat Them

About Blood Clots and How to Treat Them PATIENT & CAREGIVER EDUCATION About Blood Clots and How to Treat Them This information describes what a blood clot is and how it is treated. About Blood Clots When you have a cut or an injury, your blood

More information

Deep Vein Thrombosis

Deep Vein Thrombosis Deep Vein Thrombosis Introduction Deep vein thrombosis (DVT) is a blood clot in a vein. This condition can affect men and women of any age and race. DVT is a potentially serious condition. If not treated,

More information

Preventing Venous Thromboembolism (VTE)

Preventing Venous Thromboembolism (VTE) INTERNET INFORMATION SOURCES North American Thrombosis Forum www.natfonline.org Clot Care www.clotcare.com MANITOUWADGE GENERAL HOSPITAL National Alliance for Thrombosis/Thrombophilia www.stoptheclot.org

More information

Venous Thromboembolism (VTE) A guide for patients with cancer

Venous Thromboembolism (VTE) A guide for patients with cancer Cancer Patient InformationPtient Education Inform Venous Thromboembolism (VTE) A guide for patients with cancer Table of Contents Venous Thromboembolism (VTE)... 3 Deep Vein Thrombosis (DVT) and Pulmonary

More information

How to prevent blood clots whilst in hospital and after your return home

How to prevent blood clots whilst in hospital and after your return home How to prevent blood clots whilst in hospital and after your return home Patient information WHAT What IS is DEEP deep VEIN vein THROMBOSIS? thrombosis? Deep Vein Thrombosis DVT is a blood clot within

More information

Understand. your risk of. blood clot

Understand. your risk of. blood clot Going into hospital? Understand how to reduce your risk of developing a blood clot Printing of this leaflet has been supported by a donation from Bayer HealthCare. Bayer HealthCare has had no editorial

More information

MEDICATION GUIDE PRADAXA (pra dax a) (dabigatran etexilate mesylate) capsules

MEDICATION GUIDE PRADAXA (pra dax a) (dabigatran etexilate mesylate) capsules MEDICATION GUIDE PRADAXA (pra dax a) (dabigatran etexilate mesylate) capsules Read this Medication Guide before you start taking PRADAXA and each time you get a refill. There may be new information. This

More information

Anticoagulant treatment for DVT

Anticoagulant treatment for DVT Anticoagulant treatment for DVT A guide to your diagnosis and the choice of treatment For more information, please contact: Please see contact details on page 23 of this booklet Caring with pride 2 Caring

More information

Package leaflet: Information for the patient. Provera 2.5mg, 5mg and 10mg Tablets Medroxyprogesterone acetate

Package leaflet: Information for the patient. Provera 2.5mg, 5mg and 10mg Tablets Medroxyprogesterone acetate Package leaflet: Information for the patient Provera 2.5mg, 5mg and 10mg Tablets Medroxyprogesterone acetate Read all of this leaflet carefully before you start using this medicine because it contains

More information

MEDICATION GUIDE JANTOVEN (JAN-to-ven) Tablets (Warfarin Sodium Tablets, USP)

MEDICATION GUIDE JANTOVEN (JAN-to-ven) Tablets (Warfarin Sodium Tablets, USP) MEDICATION GUIDE JANTOVEN (JAN-to-ven) Tablets (Warfarin Sodium Tablets, USP) Read this Medication Guide before you start taking JANTOVEN (Warfarin Sodium Tablets, USP) and each time you get a refill.

More information

PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET

PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET PROPOSED PATIENT INFORMATION LEAFLET FOR PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET SCHEDULING STATUS S3 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM PHARMA DYNAMICS CLOPIDOGREL

More information

Things to Know When Taking Warfarin (Coumadin ) Anticoagulation Therapy

Things to Know When Taking Warfarin (Coumadin ) Anticoagulation Therapy Things to Know When Taking Warfarin (Coumadin ) Anticoagulation Therapy Table of Contents Highlights... 1 Why Do I Need Warfarin (Coumadin )?... 1 Who is Going to be Taking Care of My Warfarin?... 1 What

More information

Pulmonary embolism. Information for patients Specialised Medicine

Pulmonary embolism. Information for patients Specialised Medicine Pulmonary embolism Information for patients Specialised Medicine page 2 of 8 What is a pulmonary embolism? A blood clot that has formed inside one of your veins, usually in your leg, is called a deep vein

More information

Inferior Vena Cava Filter for DVT

Inferior Vena Cava Filter for DVT Inferior Vena Cava Filter for DVT Deep Vein Thrombosis A deep vein thrombosis (DVT) is a blood clot that forms in a deep vein. This is a serious condition that occurs more often than you might think. If

More information

Living with a New Oral Anticoagulant (NOAC)

Living with a New Oral Anticoagulant (NOAC) Living with a New Oral Anticoagulant (NOAC) dabigatran (Pradaxa ) rivaroxaban (Xarelto ) apixaban (Eliquis ) Information for patients Produced and made available by the Western Australian Medication Safety

More information

Direct Oral Anticoagulant (DOAC)Therapy. Important information for patients prescribed: Apixaban, Dabigatran, Edoxaban or Rivaroxaban

Direct Oral Anticoagulant (DOAC)Therapy. Important information for patients prescribed: Apixaban, Dabigatran, Edoxaban or Rivaroxaban Direct Oral Anticoagulant (DOAC)Therapy Important information for patients prescribed: Apixaban, Dabigatran, Edoxaban or Rivaroxaban Patient Name: Address: Postcode: CHI Number: Condition requiring treatment:

More information

These findings add to existing published research examining reversal measures for blood thinners:

These findings add to existing published research examining reversal measures for blood thinners: March 2, 2015 Findings to be Presented at Annual Scientific Session of the American College of Cardiology (ACC) About an Additional Potential Reversal Strategy for and Real-World Safety Performance of

More information

Inlyta (axitinib) for Kidney Cancer

Inlyta (axitinib) for Kidney Cancer Inlyta (axitinib) for Kidney Cancer Inlyta is a medication used to treat advanced kidney cancer in adults when one prior drug treatment for this disease has not worked Dosage: 5mg taken twice a day How

More information

ARE YOU HAVING HIP OR KNEE REPLACEMENT SURGERY?

ARE YOU HAVING HIP OR KNEE REPLACEMENT SURGERY? ARE YOU HAVING HIP OR KNEE REPLACEMENT SURGERY? GET TO KNOW HOW THIS LATEST-GENERATION BLOOD THINNER HELPS PROTECT YOU FROM BLOOD CLOTS. Once I got the facts, my doctor and I chose XARELTO Do not stop

More information

Dabigatran (Pradaxa )

Dabigatran (Pradaxa ) What is dabigatran (Pradaxa )? Dabigatran is also called Pradaxa Dabigatran (Pradaxa ) is used to reduce the risk of blood clots and stroke in people with an abnormal heart rhythm known as atrial fibrillation,

More information

Pulmonary Embolism (PE)

Pulmonary Embolism (PE) Pulmonary Embolism (PE) Normally blood moves freely throughout the body without any problems. However, if a blood clot forms in a vein it can block the vein and stop the blood from flowing properly. Sometimes

More information

QUESTIONS AND ANSWERS ON COMBINED HORMONAL CONTRACEPTIVES: LATEST INFORMATION FOR WOMEN

QUESTIONS AND ANSWERS ON COMBINED HORMONAL CONTRACEPTIVES: LATEST INFORMATION FOR WOMEN QUESTIONS AND ANSWERS ON COMBINED HORMONAL CONTRACEPTIVES: LATEST INFORMATION FOR WOMEN Why is new information being made available now? A recent Europe wide review looked at the benefits and risks of

More information

SAFE study A-fib ED Anticoagulation Package

SAFE study A-fib ED Anticoagulation Package SAFE study A-fib ED Anticoagulation Package In this package you will find documents to help you make decision making easy for the Anticoagulation of New AFib patients being discharged from the ED: 1. Anticoagulation

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Raloxifen STADA 60 mg film-coated tablets (raloxifene hydrochloride)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Raloxifen STADA 60 mg film-coated tablets (raloxifene hydrochloride) PACKAGE LEAFLET 1 PACKAGE LEAFLET: INFORMATION FOR THE USER Raloxifen STADA 60 mg film-coated tablets (raloxifene hydrochloride) Please read this information carefully before you start to take your medicine.

More information

Package leaflet: Information for the patient. Olumiant 2 mg film-coated tablets Olumiant 4 mg film-coated tablets Baricitinib

Package leaflet: Information for the patient. Olumiant 2 mg film-coated tablets Olumiant 4 mg film-coated tablets Baricitinib Package leaflet: Information for the patient Olumiant 2 mg film-coated tablets Olumiant 4 mg film-coated tablets Baricitinib This medicine is subject to additional monitoring. This will allow quick identification

More information

Deep vein thrombosis (DVT) and pulmonary embolism (PE) advice for ophthalmic surgery patients

Deep vein thrombosis (DVT) and pulmonary embolism (PE) advice for ophthalmic surgery patients Deep vein thrombosis (DVT) and pulmonary embolism (PE) advice for ophthalmic surgery patients What is a deep vein thrombosis (DVT)? A DVT is a blood clot that forms within a vein deep in the leg but can

More information

Your treatment with XELJANZ

Your treatment with XELJANZ Your treatment with XELJANZ (tofacitinib citrate) THIS BROCHURE HAS BEEN PRODUCED FOR PATIENTS WHO HAVE BEEN PRESCRIBED XELJANZ. BEFORE USING XELJANZ, PLEASE REVIEW THE PACKAGE LEAFLET FOR THIS MEDICINAL

More information

Dabigatran. (Da. medication do? What does this. Medication. very fast.

Dabigatran. (Da. medication do? What does this. Medication. very fast. Medication Information (Da big a tran) Other names for this medication are: Pradaxa What does this medication do? This medication is a blood thinner, also called an anticoagulant. It prevents a blood clot

More information

Venous Thromboembolism (VTE)

Venous Thromboembolism (VTE) Venous Thromboembolism (VTE) Nursing A guide for patients and carers Contents Why do blood clots form in veins?... 1 How common is a deep vein thrombosis (DVT) or pulmonary embolus (PE)?... 2 How are DVTs/

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES. Lubiprostone

PACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES. Lubiprostone PACKAGE LEAFLET PACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES Lubiprostone This medicine is subject to additional monitoring. This will allow quick identification of new

More information

1. What is fulvestrant?

1. What is fulvestrant? Talk to our breast care nurses 0808 800 6000 1. What is fulvestrant? 2. How does fulvestrant work? 3. When might fulvestrant be prescribed? 4. How is fulvestrant given? 5. How long will I be given fulvestrant

More information

Patient Information. Preventing and treating blood clots

Patient Information. Preventing and treating blood clots Patient Information Preventing and treating blood clots 1_Clexane_Patient_Booklet_AW05.indd 1 8/04/2016 11:26 a The information provided in this document is for patients prescribed CLEXANE, and should

More information

What is Warfarin? 1 Light Brown 3 Light Blue 5 Pink

What is Warfarin? 1 Light Brown 3 Light Blue 5 Pink Pharmacy Warfarin What is Warfarin? Warfarin is an anticoagulant, sometimes called a blood thinner. It prevents blood clots from forming and also prevents existing clots in the blood vessels from getting

More information

Clinical Guide - Patient Information (January 2007)

Clinical Guide - Patient Information (January 2007) Clinical Guide - Patient Information (January 2007) Principal Developer: B. Bartle Secondary Developers: J. Johnson, M-F. Scully, L. Vickars Information For Patients Taking Oral Anticoagulants You are

More information

How Entecavir GH Works

How Entecavir GH Works entecavir monohydrate tablets ENTECAVIR GH Tablets Consumer Medicine Information What is in this leaflet Read this leaflet carefully before taking. This leaflet answers some common questions about. It

More information

For the Patient: UMYLDREL

For the Patient: UMYLDREL For the Patient: UMYLDREL Other Names: Treatment of Multiple Myeloma Using Lenalidomide (REVLIMID ) and Dexamethasone MY = MYeloma (tumour group) L = Lenalidomide D = Dexamethasone REL = RELapse Uses:

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Fibrovein 3%, 1%, 0.5% and 0.2% Solution for Injection Sodium tetradecyl sulphate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Fibrovein 3%, 1%, 0.5% and 0.2% Solution for Injection Sodium tetradecyl sulphate PACKAGE LEAFLET: INFORMATION FOR THE USER Fibrovein 3%, 1%, 0.5% and 0.2% Solution for Injection Sodium tetradecyl sulphate Read all of this leaflet carefully before you start using this medicine. Keep

More information

Motens 2 mg and 4 mg Tablets lacidipine

Motens 2 mg and 4 mg Tablets lacidipine Package leaflet: Information for the user Motens 2 mg and 4 mg Tablets lacidipine Read all of this leaflet carefully before you start taking this medicine because it contains important information for

More information

Treating your Deep Vein Thrombosis and Pulmonary Embolism with. Useful information and self-help guide. This leaflet has been produced by LEO Pharma

Treating your Deep Vein Thrombosis and Pulmonary Embolism with. Useful information and self-help guide. This leaflet has been produced by LEO Pharma Treating your Deep Vein Thrombosis and Pulmonary Embolism with Useful information and self-help guide This leaflet has been produced by LEO Pharma Contents Useful information Useful information 3 Introduction

More information

What is in this leaflet

What is in this leaflet 1 Consumer Medicine Information Tranexamic acid Film coated tablets, 500 mg What is in this leaflet Please read this leaflet carefully before you start taking. This leaflet answers some common questions

More information

Traztuzumab (Herceptin)

Traztuzumab (Herceptin) Traztuzumab (Herceptin) Information for patients Chemotherapy Name Hospital No Your consultant is Important Advice Always carry your chemotherapy alert card. It is important that you know what to do if

More information

DO YOU HAVE AFIB OR DVT/PE BLOOD CLOTS?

DO YOU HAVE AFIB OR DVT/PE BLOOD CLOTS? To significantly reduce stroke risk from AFib and to treat and help prevent DVT and PE blood clots DO YOU HAVE AFIB OR DVT/PE BLOOD CLOTS? GET TO KNOW HOW THIS LATEST-GENERATION BLOOD THINNER HELPS PROTECT

More information

PACKAGE LEAFLET. Page 1 of 8

PACKAGE LEAFLET. Page 1 of 8 PACKAGE LEAFLET Page 1 of 8 Package leaflet: Information for the patient Temazepam 10mg and 20mg tablets (Temazepam) Read all of this leaflet carefully before you start taking this medicine because it

More information

For males: use effective birth control during your treatment with INLYTA. Talk to your doctor about birth control methods.

For males: use effective birth control during your treatment with INLYTA. Talk to your doctor about birth control methods. PATIENT INFORMATION INLYTA (in-ly-ta) (axitinib) tablets Read this Patient Information before you start taking INLYTA and each time you get a refill. There may be new information. This information does

More information

A Patient Information Guide My Guide to HCV treatment and care. Helpful information for patients who have been prescribed MAVIRET

A Patient Information Guide My Guide to HCV treatment and care. Helpful information for patients who have been prescribed MAVIRET A Patient Information Guide My Guide to HCV treatment and care Helpful information for patients who have been prescribed MAVIRET The information in this booklet does not replace the Patient Information

More information

Package leaflet: Information for the user. Levonorgestrel 1.5 mg Tablet. levonorgestrel

Package leaflet: Information for the user. Levonorgestrel 1.5 mg Tablet. levonorgestrel Package leaflet: Information for the user Levonorgestrel 1.5 mg Tablet levonorgestrel Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

JINARC (tolvaptan) Patient/carer education brochure

JINARC (tolvaptan) Patient/carer education brochure JINARC (tolvaptan) Patient/carer education brochure This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side

More information

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate PACKAGE LEAFLET Package leaflet: Information for the patient Calcium Folinate 15 mg Tablets calcium folinate Read all of this leaflet carefully before you start taking this medicine because it contains

More information

KAMIREN PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1. WHAT KAMIREN IS AND WHAT IT IS USED FOR

KAMIREN PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1. WHAT KAMIREN IS AND WHAT IT IS USED FOR PACKAGE LEAFLET: INFORMATION FOR THE USER KAMIREN 2 mg, 4 mg TABLETS DOXAZOSIN This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines

More information

All medicines have risks and benefits. Your doctor has weighed the risks of you taking Triprim against the benefits he or she expects it will have.

All medicines have risks and benefits. Your doctor has weighed the risks of you taking Triprim against the benefits he or she expects it will have. Triprim Tablets Trimethoprim Tablets Consumer Medicine Information What is in this leaflet? The leaflet answers some common questions about Triprim tablets. It does not contain all the available information

More information

Package leaflet: Information for the patient. Heparin Sodium BP 1000 IU/L in 0.9% w/v Sodium Chloride IV Infusion. Active substance: Heparin Sodium

Package leaflet: Information for the patient. Heparin Sodium BP 1000 IU/L in 0.9% w/v Sodium Chloride IV Infusion. Active substance: Heparin Sodium Package leaflet: Information for the patient Heparin Sodium BP 1000 IU/L in 0.9% w/v Sodium Chloride IV Infusion Active substance: Heparin Sodium Read all of this leaflet carefully before you are given

More information

Deep Vein Thrombosis and Pulmonary Embolism: Patient Information

Deep Vein Thrombosis and Pulmonary Embolism: Patient Information Deep Vein Thrombosis and Pulmonary Embolism: Patient Information A Deep Vein Thrombosis (DVT) and a Pulmonary Embolism (PE) are both disorders of unwanted blood clotting. Unwanted blood clots can occur

More information

Helping to prevent stroke caused by non-valvular atrial fibrillation Information booklet

Helping to prevent stroke caused by non-valvular atrial fibrillation Information booklet Helping to prevent stroke caused by non-valvular atrial fibrillation Information booklet IF FOUND, PLEASE RETURN TO: Name Address Phone number Contents ALERT CARD...2 BOOKLET INFORMATION...3 What is atrial

More information

(pack li TAX ell) For treating breast cancer, lung cancer, ovarian cancer, Kaposi's sarcoma or other cancers

(pack li TAX ell) For treating breast cancer, lung cancer, ovarian cancer, Kaposi's sarcoma or other cancers Medication Information Sheet (pack li TAX ell) This document provides general information about your medication. It does not replace the advice of your health care professional. Always discuss your therapy

More information

Important safety information to minimise the risk of immune-related adverse reactions

Important safety information to minimise the risk of immune-related adverse reactions Your Guide to KEYTRUDA (pembrolizumab) Important safety information to minimise the risk of immune-related adverse reactions Information for Patients This medicine is subject to additional monitoring.

More information

Information for patients and families

Information for patients and families Information for patients and families What is Factor V Leiden? Factor V Leiden is a blood clotting disorder. It is not a disease. Factor V is a protein that is needed for blood to clot properly. Some people

More information

AN ADVANCEMENT FOR POSTMENOPAUSAL WOMEN WITH ER+/HER2- METASTATIC BREAST CANCER.

AN ADVANCEMENT FOR POSTMENOPAUSAL WOMEN WITH ER+/HER2- METASTATIC BREAST CANCER. For estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer. AN ADVANCEMENT FOR POSTMENOPAUSAL WOMEN WITH ER+/HER2- METASTATIC BREAST CANCER.

More information

Sunitinib. Other Names: Sutent. About This Drug. Possible Side Effects. Warnings and Precautions

Sunitinib. Other Names: Sutent. About This Drug. Possible Side Effects. Warnings and Precautions Sunitinib Other Names: Sutent About This Drug Sunitnib is used to treat cancer. It is given orally (by mouth). Possible Side Effects Headache Tiredness and weakness Soreness of the mouth and throat. You

More information

Northumbria Healthcare NHS Foundation Trust. Laparoscopic Cholecystectomy. Issued by the Department of Upper Gastrointestinal Surgery

Northumbria Healthcare NHS Foundation Trust. Laparoscopic Cholecystectomy. Issued by the Department of Upper Gastrointestinal Surgery Northumbria Healthcare NHS Foundation Trust Laparoscopic Cholecystectomy Issued by the Department of Upper Gastrointestinal Surgery Laparoscopic Cholecystectomy This leaflet explains why you have been

More information

Patient Information VERSACLOZ (VER sa kloz) (clozapine) Oral Suspension

Patient Information VERSACLOZ (VER sa kloz) (clozapine) Oral Suspension Patient Information VERSACLOZ (VER sa kloz) (clozapine) Oral Suspension Read this Patient Information before you start taking VERSACLOZ and each time you get a refill. There may be new information. This

More information

Cyclophosphamide Treatment (To be used in conjunction with the Shared Care Blood Test Monitoring Card)

Cyclophosphamide Treatment (To be used in conjunction with the Shared Care Blood Test Monitoring Card) Cyclophosphamide Treatment (To be used in conjunction with the Shared Care Blood Test Monitoring Card) Exceptional healthcare, personally delivered What is Cyclophosphamide Cyclophosphamide is a potent

More information

SANDOMIGRAN. 0.5mg tablet Pizotifen malate

SANDOMIGRAN. 0.5mg tablet Pizotifen malate SANDOMIGRAN 0.5mg tablet Pizotifen malate What is in this leaflet This leaflet answers some common questions about Sandomigran. It does not contain all the available information. It does not take the place

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER Clotrimazole Cream 1%

PACKAGE LEAFLET: INFORMATION FOR THE USER Clotrimazole Cream 1% PACKAGE LEAFLET PACKAGE LEAFLET: INFORMATION FOR THE USER Clotrimazole Cream 1% Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET SCHEDULING STATUS: S4 PROPRIETARY NAME AND PHARMACEUTICAL FORM: XARELTO 15 Film-coated tablets XARELTO 20 Film-coated tablets Read all of this leaflet carefully before you start

More information

Elements for a Public Summary Overview of disease epidemiology

Elements for a Public Summary Overview of disease epidemiology VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Indication: Treatment of blood clots Blood clots in the large veins of the legs, known as deep vein thrombosis (DVT), are a common

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Aciclovir 400 mg Tablets Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this

More information

Deep Vein Thrombosis or Pulmonary Embolism

Deep Vein Thrombosis or Pulmonary Embolism What You Need to Know After Deep Vein Thrombosis or Pulmonary Embolism The content provided here is for informational purposes only. It is not intended to diagnose or treat a health problem or disease,

More information

If you have any concerns about taking this medicine, ask your doctor or pharmacist.

If you have any concerns about taking this medicine, ask your doctor or pharmacist. ISENTRESS raltegravir 400 mg tablet What is in this leaflet This leaflet answers some common questions about ISENTRESS. It does not contain all the available information. It does not take the place of

More information

TREANA 5mg and 10mg Film-coated Tablets

TREANA 5mg and 10mg Film-coated Tablets PACKAGE LEAFLET: INFORMATION FOR THE USER TREANA 5mg and 10mg Film-coated Tablets OLANZAPINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,

More information

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate)

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate) PACKAGE LEAFLET: INFORMATION FOR THE PATIENT Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate) Pfizer Logo Read all of this leaflet carefully before you start taking this

More information

FDA Approves New 10 mg Dosing for XARELTO (rivaroxaban) to Reduce the Continued Risk of Venous Thromboembolism (VTE)

FDA Approves New 10 mg Dosing for XARELTO (rivaroxaban) to Reduce the Continued Risk of Venous Thromboembolism (VTE) Media Contacts: Sarah Freeman Mobile: (215) 510-4758 sfreem21@its.jnj.com Christina Chan Office: (908) 927-5769 Mobile: (908) 635-2406 cchan20@its.jnj.com Investor Relations Contacts: Johnson & Johnson

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin PACKAGE LEAFLET: INFORMATION FOR THE USER XIFAXANTA 200 mg film-coated tablets Rifaximin Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

For the Patient: Lenvatinib Other names: LENVIMA

For the Patient: Lenvatinib Other names: LENVIMA For the Patient: Lenvatinib Other names: LENVIMA Lenvatinib (len va' ti nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth. Tell your doctor if you have ever

More information

Bonefos 400 mg capsules sodium clodronate

Bonefos 400 mg capsules sodium clodronate Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack. Please compare the 'Leaflet prepared/revised date' towards the end

More information

For the Patient: Ponatinib Other names: ICLUSIG

For the Patient: Ponatinib Other names: ICLUSIG For the Patient: Other names: ICLUSIG (poe na' ti nib) is a drug that is used to treat some types of cancer. It is a tablet that you take by mouth. The tablet contains lactose. Tell your doctor if you

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium PACKAGE LEAFLET: INFORMATION FOR THE USER Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium Read all of this leaflet carefully before you start taking this medicine because it contains

More information